Harbour Investments’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
VCM
VPM
EIG
Harbour Investments's DGX Position: Q1 2026 in Review
Harbour Investments increased its Quest Diagnostics (DGX) stake by 61% in Q1 2026, buying an estimated $51.3K and bringing the position to 696 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #1745.
Harbour Investments first reported a position in DGX in Q1 2021 and has held it in 20 quarters since. The position peaked at $272K in Q3 2021. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Harbour Investments held 696 shares of Quest Diagnostics worth $137K as of Q1 2026.
- Harbour Investments bought 264 Quest Diagnostics shares in Q1 2026, an estimated $51.3K.
- Quest Diagnostics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #1745 holding.
- Harbour Investments first reported a position in Quest Diagnostics in Q1 2021 and has held it in 20 quarters since.
- Harbour Investments's Quest Diagnostics position peaked at $272K in Q3 2021.
- 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.